Genexine ranked among the top searched stocks on 2 days within the past month.

As of 9:30 AM on the 12th, Genexine is trading at 93,500 KRW, up 0.11% from the previous day. This represents a 40.18% increase compared to May 15. Genexine is known as a company specializing in the development of biopharmaceuticals.

Over the past 5 days, individual investors have net purchased 70,716 shares, while foreigners and institutions have net purchased 217,894 shares and net sold 130,732 shares, respectively.

On June 11, Genexine was a market topic due to the "strong performance following the approval of COVID-19 vaccine clinical trials in the U.S."

※Source: AI Investment Assistant AI Lasso

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing